Bumper Offer - Urjas oil Just @ Rs. 1
CA 007 500/2000 Injection 10 Ml is a prescription medicine that is available as a Injection. Secondary and off-label uses of CA 007 500/2000 Injection 10 Ml have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of CA 007 500/2000 Injection 10 Ml. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, CA 007 500/2000 Injection 10 Ml can also lead to other problems, which have been listed below. Normally, these side effects of CA 007 500/2000 Injection 10 Ml are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, CA 007 500/2000 Injection 10 Ml's effect is Safe during pregnancy and Mild for lactating mothers. Further, the section on CA 007 500/2000 Injection 10 Ml related warnings talks about CA 007 500/2000 Injection 10 Ml's effects on the liver, heart and kidney.
CA 007 500/2000 Injection 10 Ml is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. Other contraindications of CA 007 500/2000 Injection 10 Ml have been discussed in the sections ahead.
Drug interactions for CA 007 500/2000 Injection 10 Ml have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that CA 007 500/2000 Injection 10 Ml is not safe while driving, and is is not addictive in nature.
CA 007 500/2000 Injection 10 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when CA 007 500/2000 Injection 10 Ml is used -
Moderate
Mild
Unknown
Is the use of CA 007 500/2000 Injection 10 Ml safe for pregnant women?
Pregnant women can take CA 007 without worrying about any side effects.
Is the use of CA 007 500/2000 Injection 10 Ml safe during breastfeeding?
Side effects of CA 007 for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of CA 007 500/2000 Injection 10 Ml on the Kidneys?
CA 007 rarely affects the kidneys.
What is the effect of CA 007 500/2000 Injection 10 Ml on the Liver?
Using CA 007 does not have any harmful effects on the liver.
What is the effect of CA 007 500/2000 Injection 10 Ml on the Heart?
Using CA 007 does not have any harmful effects on the heart.
CA 007 500/2000 Injection 10 Ml should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take CA 007 500/2000 Injection 10 Ml unless your doctor advises you to do so -
Is this CA 007 500/2000 Injection 10 Ml habit forming or addictive?
No, you will not get addicted to CA 007 500/2000 Injection 10 Ml.
Interaction between Food and CA 007 500/2000 Injection 10 Ml
Taking CA 007 500/2000 Injection 10 Ml with food does not harm your health.
Interaction between Alcohol and CA 007 500/2000 Injection 10 Ml
It is difficult to say anything about the effect of CA 007 500/2000 Injection 10 Ml and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)